Illumina Inc (OQ:ILMN)
Business Focus: Advanced Medical Equipment & Technology
| Sector: Healthcare | Industry: Advanced Medical Equipment & Technology |
| See Regulatory Filings on SEC | |
| Company Contact | |
| Address: | 5200 Illumina Way SAN DIEGO CA 92122-4616 |
| Tel: | N/A |
| Website: | https://www.illumina.com |
| IR: | See website |
| Key People | ||
| Jacob Thaysen Chief Executive Officer, Director | Jakob Wedel Chief Strategy and Corporate Development Officer | Ankur Dhingra Chief Financial Officer |
| Aimee L. Hoyt Chief People Officer | Charles E. Dadswell Senior Vice President, General Counsel, Company Secretary | Steve Barnard Chief Technology Officer |
| Carissa L. Rollins Chief Information Officer | Kathryne Reeves Chief Marketing Officer | Kevin Carl Pegels Chief of Global Operations | Bas Verhoef Interim Chief Commercial Officer |
| Business Overview |
| Illumina, Inc. is a provider of sequencing and array-based solutions for genetic and genomic analysis. The Company operates through two segments: Core Illumina and GRAIL. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis. Its BaseSpace Informatics Suite integrates directly with its sequencing instruments, allowing customers to manage their biological sample and sequencing runs, process and analyze the raw genomic data, and derive results. Its BeadArray technology combines microscopic beads and a substrate in a proprietary manufacturing process to produce arrays that can perform various assays simultaneously. |
| Financial Overview |
| For the fiscal year ended 31 December 2023, Illumina Inc revenues decreased 2% to $4.5B. Net loss decreased 74% to $1.16B. Revenues reflect Greater China segment decrease of 19% to $384M, Europe, Middle East, and Africa segment decrease of 6% to $1.14B, Americas segment decrease of 14% to $162M. Lower net loss reflects GRAIL segment loss decrease of 65% to $1.62B, Core Illumina segment income increase of 15% to $552M. |
| Employees: | 10,590 as of Dec 31, 2023 |
| Reporting Currency: | U.S. Dollars |
| Enterprise value: | $20,256M as of Dec 31, 2023 |
| Annual revenue (TTM): | $4,504M as of Dec 31, 2023 |
| EBITDA (TTM): | $359.00M as of Dec 31, 2023 |
| Net annual income (TTM): | -$1,160M as of Dec 31, 2023 |
| Free cash flow (TTM): | $282.00M as of Dec 31, 2023 |
| Net Debt Last Fiscal Year: | $435.00M as of Dec 31, 2023 |
| Shares outstanding: | 159,255,385 as of Mar 22, 2024 |
| Index Membership: | S&P 500 |
| TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization | |
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.